Corrigendum“Corrections to Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC”
Under a Creative Commons license
open access
Cited by (0)
Copyright © 2018 THE AUTHORS. Published by Elsevier Ltd.